Literature DB >> 19748188

The Double Strike Hypothesis of the vitiligo pathomechanism: new approaches to vitiligo and melanoma.

Dirk Michelsen1.   

Abstract

Based on current research, we present a consolidated set of theses which explain the pathomechanisms of vitiligo- and melanoma-associated hypopigmentation. The main thesis is the Double Strike Hypothesis, i.e. vitiligo is caused by at least two different major pathomechanisms: an antibody-based pathomechanism and a T-cell-based pathomechanism. The antibody-based pathomechanism is dominant in diffuse vitiligo, while the T-cell based pathomechanism is dominant in localised vitiligo. Based on this main thesis we derive new therapeutical approaches to vitiligo and melanoma by using the different pathomechanisms. Finally we explain why melanoma-associated hypopigmentation as a natural immunotherapy is still in statu nascendi.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748188     DOI: 10.1016/j.mehy.2009.08.008

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

Review 1.  New perspectives on the role of vitiligo in immune responses to melanoma.

Authors:  Katelyn T Byrne; Mary Jo Turk
Journal:  Oncotarget       Date:  2011-09

2.  Comparison of tyrosinase antibody, tyrosinase-related protein-1 and -2 antibodies, melanin-concentrating hormone receptor antibody levels with autologous serum skin test and autologous plasma skin test results in patients with vitiligo.

Authors:  Abdullah Unal; Hatice Uce Ozkol; Yasemin Bayram; Necmettin Akdeniz
Journal:  Postepy Dermatol Alergol       Date:  2020-02-25       Impact factor: 1.837

3.  Reduced risk of skin cancer and internal malignancies in vitiligo patients: a retrospective population-based cohort study in Taiwan.

Authors:  Yu-Ching Weng; Hsiu J Ho; Yi-Ling Chang; Yun-Ting Chang; Chun-Ying Wu; Yi-Ju Chen
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

Review 4.  Concise review of recent studies in vitiligo.

Authors:  Mohamed Allam; Hassan Riad
Journal:  Qatar Med J       Date:  2013-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.